LISAvienna: Biotech delegation from Luxembourg visits Life Science location Vienna

Vienna, April 2013 - During the official visit by the Grand Duke of Luxembourg in Austria the Vienna Life Science Cluster organization LISAvienna organized a partnering and delegation visit for 6 Life Science companies and research institutes from Luxembourg.

In recent years the Grand Duchy of Luxembourg has developed into a specialized Biotechnology location mainly thanks to the foundation of the University of Luxembourg and the numerous support measures by the Luxembourg Innovation Agency Luxinnovation. Biotechnology was therefore a major focus of the official state visit by the Grand Duke of Luxembourg.

LISAvienna prepared a life science delegation visit focusing on leading research institutes such as the Austrian Institute of Technology (AIT), the Center of Molecular Medicine (CeMM) and the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Science as well as the Institute of Molecular Pathology (IMP) and the Children´s Cancer Research Institute (CCRI). During the visit the Institute of Hygiene of the Medical University of Vienna and the Centre de Recherche Public Santé (CRP-Santé), Institute of Immunology signed a cooperation agreement thereby intensifying their joint research work on Borreliosis.

In addition to the visit program, the delegation from Luxembourg received insights into the activities of the Vienna biotechnology companies AFFiRiS and APEIRON Biologics. Further opportunity for exchange was provided at the State reception in the Albertina.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)